PRIMROSE THERAPEUTICS
Primrose Therapeutics, Inc. is a biotechnology company focused on the development of treatments for Polycystic Kidney Disease (PKD). PKD is one of the most common life-threatening genetic disorders, affecting 600,000 Americans and 12.5 million people worldwide -- more than cystic fibrosis, muscular dystrophy, hemophilia, Down syndrome and sickle cell anemia combined. PKD results in the abnormal growth of cells in the kidney, which eventually lead to the development of bilateral kidney cysts and structural destruction of the kidney. The average lifespan of PKD patients is 64 years -- at least a decade shorter than average. No FDA approved therapies currently exist for this devastating disease.
PRIMROSE THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2010-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.primrosetherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
212-632-5404
Email Addresses:
[email protected]
Total Funding:
752.55 K USD
Technology used in webpage:
Domain Not Resolving
Current Employees Featured
Founder
Official Site Inspections
http://www.primrosetherapeutics.com
Unable to get host informations!!!